^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
FWD1509
i
Other names: FWD1509, FWD-1509
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Shenzhen Forward Pharma
Drug class:
HER2 exon 20 mutation inhibitor
Related drugs:
over2years
A Study of FWD1509 in Adults With Non-Small Cell Lung Cancer (clinicaltrials.gov)
P1/2, N=30, Recruiting, Forward Pharmaceuticals Co., Ltd. | N=130 --> 30
Enrollment change
|
EGFR (Epidermal growth factor receptor) • HER-2 (Human epidermal growth factor receptor 2)
|
EGFR mutation • HER-2 mutation • EGFR exon 19 deletion • EGFR T790M • EGFR exon 20 insertion • EGFR L861Q • EGFR G719X • EGFR S768I • EGFR exon 20 mutation • HER-2 A775
|
FWD1509
3years
A Study of FWD1509 in Adults With Non-Small Cell Lung Cancer (clinicaltrials.gov)
P1/2, N=130, Recruiting, Forward Pharmaceuticals Co., Ltd.
Clinical • New P1/2 trial
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation • EGFR exon 19 deletion • EGFR T790M • EGFR exon 20 insertion • EGFR L861Q • EGFR exon 20 mutation
|
FWD1509
Share via
